




Risk factors for complications after pharyngolaryngectomy 
with total esophagectomy
Eisuke Booka1,4 · Yasuhiro Tsubosa1 · Masahiro Niihara1 · Wataru Takagi1 · 
Katsushi Takebayashi1 · Ayako Shimada1,4 · Takashi Kitani2 · Masato Nagaoka2 · 
Atsushi Imai2 · Tomoyuki Kamijo2 · Yoshiyuki Iida2 · Tetsuro Onitsuka2 · 
Masahiro Nakagawa3 · Hiroya Takeuchi4 · Yuko Kitagawa4 
Received: 6 February 2016 / Accepted: 15 March 2016 / Published online: 31 March 2016 
© The Author(s) 2016. This article is published with open access at Springerlink.com
Conclusion One-stage PLTE and standard mediastinal 
lymph node dissection were identified as the risk factors for 
severe postoperative complications. Staged PLTE or tran-
shiatal esophagectomy should be considered when PLTE is 
performed and standard mediastinal lymph node dissection 
should be avoided when one-stage PLTE is performed with 
transthoracic esophagectomy.
Keywords Pharyngolaryngectomy · Total 
esophagectomy · Tracheal necrosis · Esophageal cancer · 
Hypopharyngeal cancer
Introduction
Esophageal cancer is the sixth leading cause of cancer-
related mortality worldwide because of its high malignant 
potential and poor prognosis [1]. The postoperative 5-year 
survival rate in patients with American Joint Committee on 
Cancer stage I esophageal cancer is approximately 90 %; it 
decreases to 45 % in patients with stage II disease, 20 % in 
those with stage III disease, and 10 % in those with stage 
IV disease [2]. Although the efficacy of chemoradiotherapy 
for esophageal cancer has been reported [3], esophagec-
tomy remains the most viable treatment option for esopha-
geal cancer. However, esophagectomy is a highly invasive 
procedure associated with several serious postoperative 
complications such as pneumonia, anastomotic leakage, 
and recurrent laryngeal nerve paralysis, which may result in 
multiorgan failure [4]. Another clinical problem associated 
with esophageal cancer is its frequent association with syn-
chronous or metachronous gastric or head and neck cancer 
[5]. Similar to the difficulty regarding the treatment for gas-
tric tube cancer after esophagectomy previously reported 
by us [5], it is complicated to treat esophageal cancer with 
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nous or metachronous hypopharyngeal or laryngeal cancer 
and thoracic esophageal cancer, although it is more invasive 
than esophagectomy and total pharyngolaryngectomy. The 
aim of this study was to identify risk factors for complica-
tions after PLTE.
Methods From November 2002 to December 2014, a 
total of 8 patients underwent PLTE at the Shizuoka Cancer 
Center Hospital, Shizuoka, Japan. We investigated the clin-
icopathological characteristics, surgical procedures, and 
postoperative complications of these patients.
Results Of the 8 patients, 5 underwent one-stage PLTE 
and 3 underwent staged PLTE. There was no mortality in 
this study. Two cases of tracheal necrosis, two of anas-
tomotic leakage, and one of ileus were observed as post-
operative complications. Two patients who underwent 
one-stage PLTE with standard mediastinal lymph node dis-
section developed tracheal necrosis and severe anastomotic 
leakage.
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synchronous or metachronous head and neck cancer. Phar-
yngolaryngectomy with total esophagectomy (PLTE) is an 
effective surgical treatment for synchronous or metachro-
nous hypopharyngeal or laryngeal and thoracic esophageal 
cancers, although PLTE is more invasive than esophagec-
tomy and total pharyngolaryngectomy (TPL) [6–9].
The fatal complications associated with PLTE are tra-
cheal and gastric tube necrosis caused by insufficient 
blood flow [10]. PLTE is also indicated for cervicothoracic 
and cervical esophageal cancers with mediastinal lymph 
node metastasis [8]. To date, although a few earlier stud-
ies have reported the efficacy of PLTE for synchronous or 
metachronous pharyngeal and thoracic esophageal cancers 
[6–8], there has been no study investigating the differences 
between one-stage and staged PLTE. Therefore, this study 
is the first to draw a comparison between one-stage and 
staged PLTE. We hypothesized that the chosen surgical 
procedure for PLTE likely impacts the potential develop-
ment of postoperative complications. Hence, the aim of this 




From November 2002 to December 2014, a total of 375 
patients underwent esophagectomy and 140 patients 
underwent TPL at Shizuoka Cancer Center Hospital, Shi-
zuoka, Japan. In this study, 8 patients who underwent 
PLTE were retrospectively analyzed. Of these patients, 
5 underwent one-stage PLTE and 3 underwent staged 
PLTE for metachronous pharyngeal and thoracic esopha-
geal cancers. Of the 5 patients who underwent one-stage 
PLTE, 2 underwent PLTE based on the indication of cer-
vicothoracic esophageal cancer, 2 underwent PLTE based 
on the indication of synchronous pharyngeal and thoracic 
esophageal cancers, and 1 underwent PLTE based on the 
indication of synchronous cervical and thoracic esophageal 
cancers. Of the 3 patients who underwent staged PLTE for 
metachronous pharyngeal and thoracic esophageal can-
cers, 2 underwent TPL followed by esophagectomy and 
1 underwent esophagectomy followed by TPL. Clinical 
staging of esophageal and pharyngeal cancers was catego-
rized according to the International Union Against Cancer 
(UICC) 7th edition tumor–node–metastasis (TNM) classi-
fication [11].
Preoperative treatment
Of the 8 patients who underwent PLTE, 7 received preoper-
ative treatment of definitive chemoradiotherapy (dCRT) (5 
patients) or neoadjuvant chemotherapy (2 patients). Defini-
tive chemoradiotherapy comprised the concurrent adminis-
tration of approximately 60 Gy radiation with 5-fluoroura-
cil and cisplatin. Salvage surgery was indicated for residual 
or recurrent lesions after dCRT. Neoadjuvant chemotherapy 
comprised 5-fluorouracil and cisplatin.
Surgical procedure
Esophagectomy was performed through right thoracotomy, 
video-assisted thoracic surgery (VATS), or transhiatal proce-
dures by esophageal surgeons. Esophagectomy through right 
thoracotomy or VATS included standard mediastinal lymph 
node dissection. However, the dissection was avoided when 
salvage surgery was performed considering the high risk 
of complications associated with the surgery. TPL was per-
formed by esophageal or head and neck surgeons according 
to the tumor location. In this study, the reconstructed organ 
was the stomach in all cases. Pharyngogastric anastomo-
sis was performed by esophageal surgeons when the whole 
stomach or pulled-up gastric tube could reach the hypophar-
ynx. When the gastric tube had been pulled up but could 
not reach the hypopharynx, free jejunal transfer (FJT) with 
microvascular anastomosis was performed to repair the cer-
vical defect between the hypopharynx and the oral side of 
the gastric tube by plastic and reconstructive surgeons. Two 
anastomoses were required in this case: pharyngojejunal and 
jejunal gastric. Postoperative complications were categorized 
using the Clavien–Dindo (CD) classification [12, 13].
Results
Patient and clinicopathological characteristics
The clinicopathological characteristics of patients who 
underwent one-stage PLTE and staged PLTE are summa-
rized in Tables 1 and 2, respectively. The median age at the 
time of PLTE and first staged PLTE was 63.5 years (range 
43–69 years). The study cohort of 8 patients comprised 6 
males and 2 females. Standard mediastinal lymph node 
dissection was performed in all patients of staged PLTE 
(patients 6, 7, and 8) and 2 patients of one-stage PLTE 
(patients 4 and 5), whereas standard mediastinal lymph 
node dissection was avoided in all patients of salvage sur-
gery (patients 1, 2, and 3).
Patients 1 and 2 underwent dCRT and salvage PLTE for 
residual lesions. Patient 3 underwent dCRT for pharyngeal 
cancer, which resulted in a complete response. However, 
pharyngeal cancer recurrence after dCRT and synchronous 
esophageal cancer was observed in 2 lesions, which were 
subsequently treated by PLTE. Patients 4 and 5 underwent 
PLTE for synchronous double cancers.
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Patient 6 underwent TPL with FJT as the first sur-
gery. However, 25 months later, this patient underwent 
esophagectomy with posterior mediastinal gastric tube 
reconstruction. Patient 7 underwent salvage TPL with FJT 
for severe stenosis after dCRT followed 1 month later by 
esophagectomy with posterior mediastinal gastric tube 
reconstruction as the second operation. Patient 8 underwent 
salvage esophagectomy with retrosternal gastric tube 
reconstruction for residual lesions after dCRT. Twenty-
three months after salvage esophagectomy, this patient 
underwent TPL with FJT for metachronous pharyngeal 
cancer. A second operation was performed for palliative 
care, and a portion of the cervical esophagus was preserved 
with minimum invasiveness.
Table 1  Clinicopathological characteristics of patients who underwent one-stage PLTE
PLTE Pharyngolaryngectomy with total esophagectomy, cTNM clinical tumor–node–metastasis, UICC international union against cancer, Ph 
pharynx, Ce cervical esophagus, Ut upper thoracic esophagus, Mt middle thoracic esophagus, dCRT definitive chemoradiotherapy, NeoFP neo-
adjuvant chemotherapy comprised 5-fluorouracil and cisplatin, VATS video-assisted thoracic surgery, FJT free jejunal transfer
Patient Age  
(years)

























































Table 2  Clinicopathological characteristics of patients who underwent staged PLTE
PLTE Pharyngolaryngectomy with total esophagectomy, cTNM clinical tumor–node–metastasis, UICC international union against cancer, Dura-
tion duration between operations (months), Ph pharynx, Ce cervical esophagus, Ut upper thoracic esophagus, Mt middle thoracic esophagus, Lt 
lower thoracic esophagus, dCRT definitive chemoradiotherapy, NeoFP neoadjuvant chemotherapy comprised 5-fluorouracil and cisplatin, TPL 
total pharyngolaryngectomy, FJT free jejunal transfer, TTE transthoracic esophagectomy
Patient Age 
(years)
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Clinical outcome after PLTE
The clinical outcomes after PLTE for all 8 patients are 
shown in Table 3. For the patients who underwent staged 
PLTE (patients 6, 7, and 8), there were no postoperative 
complications from the first operation. The perioperative 
and postoperative outcomes of the second operation are 
shown in Table 3.
The mean operation time was 569 min (range 443–
730 min) and the median blood loss was 640 ml (range 
179–1430 ml). The median hospital stay was 28.5 days 
(range 18–99 days). There was no instance of mortal-
ity in this study. Two cases of tracheal necrosis (patients 
4 and 5), 2 of anastomotic leakage (patients 2 and 5), 
and 1 of ileus (patient 7) were observed as postoperative 
complications.
The occurrence of tracheal necrosis is shown in 
Fig. 1 (patients 4 and 5). In case of patient 4, tracheal 
necrosis was observed on postoperative day (POD) 
9 (Fig. 1a) and a tracheostomy tube was inserted 
against tracheal stenosis on POD 79. Tracheal necro-
sis improved on POD 164 (Fig. 1b). In case of patient 
5, tracheal necrosis was observed on POD 13 (Fig. 1c) 
and a tracheostomy tube was inserted against tracheal 
stenosis on POD 16. The membranous portion of the 
trachea was melted on POD 26 and fistula formation 
was observed on POD 40. Fistula closure was per-
formed on POD 77 and tracheal necrosis improved on 
POD 113 (Fig. 1d).
Patient 1 died because of lung metastasis at 14 months 
and patient 7 died because of pneumonia that were not 
related to esophageal cancer at 53 months. The remaining 
6 patients are alive, including 1 who experienced lymph 
node recurrence (patient 8) and 5 who experienced no 
recurrence.
Discussion
PLTE is an effective surgical treatment for synchronous or 
metachronous hypopharyngeal or laryngeal and thoracic 
esophageal cancers. However, PLTE is more invasive than 
esophagectomy or TPL, and it is important to prevent post-
operative complications and consider indications for this 
invasive procedure [6–8, 14].
At our institution, the eligibility criteria for PLTE were 
not clearly defined. However, we decided the criteria after 
careful consideration of all the factors that would compre-
hensively affect patient life. As a result, the average age of 
participants in this study cohort was less than usual cohort 
of esophageal cancer [15].
In this study, tracheal necrosis developed in patients 4 
and 5 and severe anastomotic leakage developed in patient 
5, and the severe anastomotic leakage was believed to 
stem from tracheal necrosis. Subsequently, these patients 
underwent transthoracic or thoracoscopic esophagectomy 
with standard mediastinal lymph node dissection, and it 
was possible that insufficient tracheal blood flow devel-
oped in response to standard mediastinal lymph node dis-
section [16]. Tracheal necrosis is considered to develop in 
response to insufficient tracheal blood flow [10, 16]. Patient 
3 underwent transthoracic esophagectomy; however, 
standard mediastinal lymph node dissection was avoided 
considering the high risk associated with salvage surgery 
[17]; therefore, tracheal blood flow was preserved. For the 
2 patients (patients 1 and 2) who underwent transhiatal 
esophagectomy, tracheal blood flow was preserved because 
mediastinal lymph node dissection was not performed. For 
the 3 patients (patients 6, 7, and 8) who underwent staged 
PLTE, transthoracic esophagectomy with standard medias-
tinal lymph node dissection was performed. However, tra-
cheal blood flow bypass was thought to have been created 
Table 3  Clinical outcome after PLTE for all 8 patients
PLTE Pharyngolaryngectomy with total esophagectomy, CD Clavien–Dindo
Patient Surgical duration (min) Blood loss (ml) Complications (CD classification) Hospital stay (day) Outcome
1 443 1430 30 Dead at 14 months (lung metas-
tasis)
2 730 1002 Anastomotic leakage (II) 27 Alive at 38 months
3 415 580 25 Alive at 37 months
4 536 183 Tracheal necrosis (IIIa) 25 Alive at 23 months
5 724 384 Anastomotic leakage (IIIb),  
tracheal necrosis (IIIa)
99 Alive at 12 months
6 414 631 18 Alive at 89 months
7 587 735 Ileus (IIIb) 45 Dead at 53 months (pneumonia)
8 702 179 32 Alive at 7 months (lymph node 
metastasis)
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in response. One-stage PLTE and standard mediastinal 
lymph node dissection were identified as risk factors of 
severe postoperative complications, particularly tracheal 
necrosis.
Staged PLTE was performed for metachronous cancers 
but not planed as the first operation in this study. In the sec-
ond operation, when the staged PLTE required efforts and 
cervical esophagus could not be resected in cases such as 
patient 8, staged PLTE may have contributed to the occur-
rence of tracheal blood flow bypass and was considered to 
be an effective procedure. Moreover, some reports have 
claimed that staged PLTE is safe and effective for high-risk 
patients [7, 8]. In this study, the shortest duration between 
the first and second procedures was 1 month, and tracheal 
blood flow bypass can occur within this period. Nonethe-
less, our experience indicates that staged PLTE could be 
effective and safe for both metachronous and synchronous 
cancers.
Definitive CRT tends to be the initial treatment for syn-
chronous double head and neck and thoracic esophageal 
cancers [7]. However, some salvage treatment is required 
in cases with either residual or recurrent disease after dCRT 
[7]. It is considered that salvage surgery after dCRT is a 
high-risk factor for severe postoperative complications [9, 
17]. In this study, 5 patients (62.5 %) underwent salvage 
PLTE after dCRT, which resulted in no instance of tracheal 
necrosis or severe anastomotic leakage. Therefore, we pro-
pose that salvage surgery can be safely performed when 
staged PLTE or transhiatal esophagectomy is selected.
In this study, those 2 patients who developed tracheal 
necrosis developed tracheal stenosis when tracheal necrosis 
improved. In these 2 patients, insertion of a tracheostomy 
tube was effective to improve tracheal stenosis. In cases in 
which tracheal stenosis cannot be avoided when tracheal 
necrosis improves, a tracheostomy tube should be inserted 
to treat tracheal stenosis [18].
In conclusion, one-stage PLTE and standard mediastinal 
lymph node dissection were identified as risk factors for 
severe postoperative complications. Staged PLTE or tran-
shiatal esophagectomy should be considered when PLTE is 
performed and standard mediastinal lymph node dissection 
should be avoided when one-stage PLTE is performed with 
transthoracic esophagectomy.
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Fig. 1  a, b Tracheal necrosis 
on postoperative day (POD) 9 
(a) and improvement on POD 
164 (b) in case 4. c, d Tracheal 
necrosis on postoperative day 
(POD) 13 (c) and improvement 
on POD 113 (d) in case 5
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